Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
- First Posted Date
- 2011-08-01
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 360
- Registration Number
- NCT01406717
- Locations
- 🇮🇳
SPIL Site 26, Hyderabad, Andhra Pradesh, India
🇮🇳SPIL Site 2, Ahmedabad, Gujrat, India
🇮🇳SPIL Site 7, Surat, Gujrat, India
Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery
- First Posted Date
- 2011-07-04
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 60
- Registration Number
- NCT01387464
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Registration Number
- NCT01288625
Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-08-30
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 169
- Registration Number
- NCT01190878
Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis
Phase 3
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2008-09-18
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Registration Number
- NCT00754949
Letrozole vs. Clomiphene Citrate in Patients With Anovulatory Infertility
- First Posted Date
- 2008-02-07
- Last Posted Date
- 2008-02-07
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 55
- Registration Number
- NCT00610077
- Locations
- 🇮🇳
IVF Centre, Chembur,, Mumbai-, Maharashtra, India
Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-21
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Sun Pharmaceutical Industries Limited
- Target Recruit Count
- 417
- Registration Number
- NCT00578955
© Copyright 2024. All Rights Reserved by MedPath